Search research articles
Contact Us
Filters
Showing results (31-40 of 148) with videos related to
Page
of 15
Sort By:
The British Journal of Psychiatry. Supplement
|
October 9, 1998
Early intervention, untreated psychosis and the course of early schizophrenia
D Linszen, M Lenior, L De Haan, et al.
Tijdschrift Voor Psychiatrie
|
March 10, 2018
[Personalised medicine for psychosis]
W Veling, I E C Sommer, R Bruggeman, et al.
Pharmacopsychiatry
|
November 21, 2012
Priorities, satisfaction and treatment goals in psychosis patients: an online consumer's survey
B Sterk, I Winter van Rossum, M Muis, et al.
Pharmacopsychiatry
|
July 9, 2014
The glutamate hypothesis: a pathogenic pathway from which pharmacological interventions have emerged
S R T Veerman, P F J Schulte, L de Haan
The American Journal of Psychiatry
|
June 1, 2000
Subjective experience and striatal dopamine D(2) receptor occupancy in patients with schizophrenia stabilized by olanzapine or risperidone
L de Haan, J Lavalaye, D Linszen, et al.
Vaccine
|
March 1, 1996
Mucosal immunogenicity of the Escherichia coli heat-labile enterotoxin: role of the A subunit
L de Haan, M Holtrop, W R Verweij, et al.
Endoscopy
|
July 6, 2007
Metastatic endometrial cancer; a rare intestinal localization
W J Thijs, A Karrenbeld, L van der Zouwen, et al.
Tijdschrift Voor Psychiatrie
|
September 8, 2006
[Residual neuropsychological, structural and functional brain abnormalities after long-term cannabis use]
M R Weeda, B D Peters, L De Haan, et al.
Acta Psychiatrica Scandinavica
|
February 11, 2016
Longitudinal association between cognitive performance and obsessive-compulsive symptoms in patients with psychosis and unaffected siblings
F Schirmbeck, M Swets, C J Meijer, et al.
Immunology
|
August 24, 1999
Mucosal immunogenicity and adjuvant activity of the recombinant A subunit of the Escherichia coli heat-labile enterotoxin
L De Haan, M Holtrop, W R Verweij, et al.
Page
of 15
Search research articles
Search
Showing results (31-40 of 148) with videos related to
Sort By:
Page
of 15
The British Journal of Psychiatry. Supplement
|
October 9, 1998
Early intervention, untreated psychosis and the course of early schizophrenia
D Linszen, M Lenior, L De Haan, et al.
Tijdschrift Voor Psychiatrie
|
March 10, 2018
[Personalised medicine for psychosis]
W Veling, I E C Sommer, R Bruggeman, et al.
Pharmacopsychiatry
|
November 21, 2012
Priorities, satisfaction and treatment goals in psychosis patients: an online consumer's survey
B Sterk, I Winter van Rossum, M Muis, et al.
Pharmacopsychiatry
|
July 9, 2014
The glutamate hypothesis: a pathogenic pathway from which pharmacological interventions have emerged
S R T Veerman, P F J Schulte, L de Haan
The American Journal of Psychiatry
|
June 1, 2000
Subjective experience and striatal dopamine D(2) receptor occupancy in patients with schizophrenia stabilized by olanzapine or risperidone
L de Haan, J Lavalaye, D Linszen, et al.
Vaccine
|
March 1, 1996
Mucosal immunogenicity of the Escherichia coli heat-labile enterotoxin: role of the A subunit
L de Haan, M Holtrop, W R Verweij, et al.
Endoscopy
|
July 6, 2007
Metastatic endometrial cancer; a rare intestinal localization
W J Thijs, A Karrenbeld, L van der Zouwen, et al.
Tijdschrift Voor Psychiatrie
|
September 8, 2006
[Residual neuropsychological, structural and functional brain abnormalities after long-term cannabis use]
M R Weeda, B D Peters, L De Haan, et al.
Acta Psychiatrica Scandinavica
|
February 11, 2016
Longitudinal association between cognitive performance and obsessive-compulsive symptoms in patients with psychosis and unaffected siblings
F Schirmbeck, M Swets, C J Meijer, et al.
Immunology
|
August 24, 1999
Mucosal immunogenicity and adjuvant activity of the recombinant A subunit of the Escherichia coli heat-labile enterotoxin
L De Haan, M Holtrop, W R Verweij, et al.
Page
of 15